Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Yeast-based immunotherapy and type I interferon sensitivity

Yeast-based immunotherapy and type I interferon sensitivity

US Patent 11304996 · Granted Apr 19, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for the treatment of COVID-19 comprising administering replication-defec2025
Lysates of recombinant yeast for inducing cellular immune responses2024
Modified yeast-brachyury immunotherapeutic compositions2021
Compositions and methods for the treatment or prevention of human immunodeficien2020
Yeast-based immunotherapy and type I interferon sensitivity2020
Yeast-based immunotherapy and type I interferon sensitivity2020
Compositions and methods for the treatment or prevention of tuberculosis2020
Compositions and methods for the treatment or prevention of hepatitis B virus in2019
Use of tumor Fas expression to determine response to anti-cancer therapy2019
Compositions and methods for the treatment or prevention of human immunodeficien2019
Compositions and methods for the treatment or prevention of tuberculosis2019
Modulation of yeast-based immunotherapy products and responses2018